Xencor, Inc.
HETERODIMERIC ANTIBODIES THAT BIND SOMATOSTATIN RECEPTOR 2
Last updated:
Abstract:
The present invention is directed to antibodies, including novel antigen binding domains and heterodimeric antibodies, that bind somatostatin receptor 2 (SSTR2)
Status:
Application
Type:
Utility
Filling date:
24 Apr 2019
Issue date:
15 Aug 2019